Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Histologic Type

Explore clinical trials studying Neoplasms by Histologic Type. Study availability and eligibility vary by location and protocol.

30,134 public trials 6,478 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Histologic Type trial results

Recruiting

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide

NCT06844383

Conditions
Adenocarcinoma, Carcinoma, Genital Diseases, +13 more
Locations
  • City of Hope Duarte, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Masonic Cancer Center Minneapolis, Minnesota, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Recruiting

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

NCT04728893

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia, +24 more
Locations
  • Highlands Oncology Group ( Site 2728) Springdale, Arkansas, United States
  • University of California San Diego Moores Cancer Center ( Site 2717) La Jolla, California, United States
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site 2724) Torrance, California, United States
  • Colorado Blood Cancer Institute ( Site 2726) Denver, Colorado, United States
View all 121 locations
View Trial Details
Recruiting

APG-115 Alone or in Combination With APG-2575 in Recurrent or Refractory Neuroblastoma or Solid Tumors

NCT05701306

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +8 more
Locations
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Tongji Hospital, Huazhong University of Science and Technology (HUST) Wuhan, Hubei, China
  • Tianjin Medical University Cancer Institute & Hospital Tianjin, Tianjin Municipality, China
View Trial Details
Recruiting

Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses

NCT07631598

Conditions
Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Community Health Project Los Angeles (CHPLA) Los Angeles, California, United States
  • HIPS Washington D.C., District of Columbia, United States
  • CARPBR/Be Safe Syringe Program Baton Rouge, Louisiana, United States
  • Harm Reduction Sisters Duluth, Minnesota, United States
View Trial Details
Recruiting

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

NCT05797168

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adnexal Diseases, +27 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Irvine, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Aurora, Colorado, United States
View all 60 locations
View Trial Details
Recruiting

Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)

NCT07297979

Conditions
Disease Attributes, Ewing Sarcoma, Neoplasms, +10 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details

Related conditions